Ocado Slips, Fresnillo Gains, Novartis Drops - podcast episode cover

Ocado Slips, Fresnillo Gains, Novartis Drops

Sep 12, 20254 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

On this episode of Stock Movers:

- Ocado shares tumbled by the most since February after a major US partner questioned the future of its warehouse networking, raising concerns that it could close existing sites as it looks to cut costs.
- Fresnillo and other European miners are outperforming on Friday thanks to a broad rise in metal prices, with gold, copper, aluminum and nickel all gaining ground.
- Novartis shares drop as much as 2.9% after the stock was downgraded to sell from neutral at Goldman Sachs. The analysts say the Swiss drugmaker’s valuation looks “stretched”.

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, Podcasts, radio News.

Speaker 2

The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.

Speaker 3

Now, let's have a look at the stocks on the move today. Here in up, I'm Caroline Hepcut alongside Tom McKenzie. I'm a joined by Bloomberg Sam on Stead. Good morning, Sam. Acado's slipping. What's behind the big drop for the well the superman not quite a supermarket retailer. They make the equipment right for warehouses.

Speaker 4

Robot warehouses, and that's really the major part of their business now that most of the joint venture that they had for retailer has gone to mar Suspencer. Kroger, the big US grosser, is probably their major customer. That's the one that people watch the most for licensing this this warehouse technology. Comments from yesterday from Kroger after the results suggesting that they're considering bringing more of their deliveries in house.

That is obviously really not good news for a Cardo because this is the kind of big flagship deal that they did for that side of their business. Shares down about ten percent. I would know Ccado quite a volatile stock, you know generally, so that you know that it might be a little bit more exacerbated than they might be for other companies, but ten percent down and really it's quite a fundamental issue if Kroger start to bring more stuff in house and don't use a Cardo's right.

Speaker 1

It is interesting, isn't it, how volatile that stock is compared to some of its some of its peers. When it comes to a very different sector, the miners, they're doing quite well. So yeah, so far in a session. What's going on with the mining sector.

Speaker 4

Well, gold miners in particular, so I mean almost the opposite its linking to the gold price. Yeah, I mean almost the opposite really of Okada. I mean not just not volatile this year, but just pretty much one direction throughout the entire year. So for as Nilo, who you just mentioned, Tom, you know, they are flying this year. They are about two hundred and seventy two hundred and eighty percent. It's pretty much consistent throughout the whole year.

Most of that is through the gold price obviously, and they're effectively printing money for themselves at the moment. They're cutting costs a lot of their minds, but gold price is going up, so everything is kind of working in their favor, and today gold moving further and further higher,

testing the record that it hit on Tuesday. Silver also going up for as Nilo for example, also Mine for silver, So all everything around these companies at the moment is working in their favor, and gold Mine is continually rising on that.

Speaker 3

Hmm, that's interesting. Let's think about the pharmaceutical sector. Nevartis is down. This is on a huge story in the US.

Speaker 4

Well, this is actually mostly on a Goldman Sachs downgrade this morning, so god and Sacks cut norv Artists to sell today. They basically said that the last few years

Navasa has been on a good run. They've been delivering really good, solid sales growth, but over the next couple of years they see that structurally shifting a little bit, bigger competition from generics coming through, and that that might result in growth just kind of generally and very structurally moving a little bit lower than it has been in the last few years. Quite a rare thing as well

as sell rating for Novartists. Almost all the analysts who cover them or either hold or buy, so that's standing out today and also a very big stock, so that's part of what's dragging the stock six hundred a little bit behind the UK's for S one hundred.

Speaker 2

To day the Stock Movers Report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android